Pharmacoepidemiology News and Research

RSS
The science of pharmacoepidemiology can answer a range of questions regarding how, why, when, where, and by whom a medicine is being used. It is a way of finding out the impact of a medicine as well as the usage results in a large, well-defined population. Also, it can help provide some indication as to how a particular drug is benefitting society and how it may be having a negative impact. Pharmacoepidemiology can be carried out both before and after a medicine is taken to market.
Diabetes treatment with low-cost generic drug can have positive implications for patient's quality of life

Diabetes treatment with low-cost generic drug can have positive implications for patient's quality of life

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

OSNP program addresses potential gaps in outpatient settings

OSNP program addresses potential gaps in outpatient settings

Antidepressant medications during pregnancy linked with increased rates of preterm birth

Antidepressant medications during pregnancy linked with increased rates of preterm birth

New AAA screening program reduces number of undiagnosed at-risk men by more than 50%

New AAA screening program reduces number of undiagnosed at-risk men by more than 50%

Use of insulin to treat type 2 diabetes has trebled in the UK, shows study

Use of insulin to treat type 2 diabetes has trebled in the UK, shows study

Study: CIEDs used by physicians today were approved as supplements to premarket approved models

Study: CIEDs used by physicians today were approved as supplements to premarket approved models

Overweight men diagnosed with prostate cancer more likely to die from the disease

Overweight men diagnosed with prostate cancer more likely to die from the disease

DPP-4 inhibitors may reduce risk of autoimmune diseases

DPP-4 inhibitors may reduce risk of autoimmune diseases

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

Deloitte announces upcoming release of PopulationMiner to improve access to patient care

Deloitte announces upcoming release of PopulationMiner to improve access to patient care

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Patients who receive automated telephone calls are more likely to have controlled hypertension

Patients who receive automated telephone calls are more likely to have controlled hypertension

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Boehringer signs agreement with Brigham to conduct long-term study program on oral anticoagulants

Boehringer signs agreement with Brigham to conduct long-term study program on oral anticoagulants

Boys more likely to receive HPV4 vaccine if their mothers receive flu shots, study finds

Boys more likely to receive HPV4 vaccine if their mothers receive flu shots, study finds

Penn Medicine's Brian L. Strom named 2013 Career Distinguished Investigator

Penn Medicine's Brian L. Strom named 2013 Career Distinguished Investigator

Study: Primary medication nonadherence can lead to increased risk of bone fractures

Study: Primary medication nonadherence can lead to increased risk of bone fractures